← Back to companies
Marea Therapeutics
0 open
San Francisco, California, United StatesFounded 202233+ employeesSeed raisedSeedPrivate
Last round: series b · $190M · Jun 2024(2 rounds total)
Backed by(8 investors)
Third Rock VenturesSofinnova InvestmentsForbion Capital PartnersPerceptive AdvisorsvenBio PartnersAlpha Wave GlobalOmega FundsSurveyor Capital
Marea Therapeutics is a clinical-stage biotechnology company harnessing the latest advances in human genetics to develop first-in-class, next-generation medicines for cardio-endocrine diseases. The company’s lead program, MAR001, is in Phase 2 clinical development for adults with metabolic dysfunction and high risk for cardiovascular disease. The company is also advancing MAR002 for the treatment of acromegaly.
Open Positions at Marea Therapeutics (0 Jobs)
No open positions at the moment.
Browse All JobsReady to start your space career at Marea Therapeutics?
